https://www.ajmc.com/view/data-make-it-clear-sglt2-inhibitors-can-be-used-in-most-common-kidney-diagnoses-says-dr-william-g-herrington
Data shows sodium-glucose cotransporter-2 (SGLT2) inhibitors are efficacious and can be used in almost all common kidney diagnoses, explained William G. Herrington, MD, MA, MBBS, Nuffield Department of Population Health, University of Oxford.
Create an account or login to join the discussion